| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $403.9M | — | +75.8% |
| Cost of Revenue | $283.5M | — | +80.8% |
| Gross Profit | $120.4M | — | +65.1% |
| R&D Expense | $1.1M | — | -55.5% |
| SG&A Expense | $27.3M | — | +52.6% |
| Operating Income | $80.3M | — | +57.6% |
| Pre-tax Income | $28.6M | — | -23.9% |
| Income Tax | -$15.5M | — | -307.6% |
| Net Income | $44.1M | — | +9.2% |
| EPS (Basic) | $0.72 | — | +7.5% |
| EPS (Diluted) | $0.71 | — | +7.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $654.6M | +344.0% | +480.9% |
| Accounts Receivable | $170.9M | +3.7% | -1.5% |
| Inventory | $45.6M | +0.6% | +8.2% |
| Current Assets | $1.08B | +81.0% | +80.1% |
| Total Assets | $6.77B | +8.4% | +16.0% |
| Current Liabilities | $1.01B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $78.6M | — | -10.7% |
| Capital Expenditures | $113.8M | — | -40.9% |
| Investing Cash Flow | -$124.5M | — | +40.1% |
| Financing Cash Flow | $528.7M | — | +280.7% |
| Free Cash Flow | -$35.2M | — | +66.3% |
| +63.5% |
| Total Liabilities | $4.05B | +14.0% | +25.0% |
| Stockholders' Equity | $2.57B | +1.1% | +4.5% |